Variation in Sex Characteristics (Restricted Medical Treatment) Act 2023

After the end of the consultation period mentioned in section 21 (2), the assessment committee must—

consider any written submissions received during the consultation period; and

either—

approve the application; or

refuse the application.

Note An application must be decided in accordance with s 13.

A decision under subsection (1) is decided by a majority of votes of all assessment committee members.

An approval is subject to—

a condition that the matters mentioned in section 16 (a) to (e) are satisfied before the restricted medical treatment is undertaken on a prescribed person; and

any other condition the assessment committee considers appropriate.

The assessment committee must give a copy of its decision under subsection (1) and the reasons for it to—

the applicant; and

each relevant entity.

An approval under this section—

is a notifiable instrument; and

expires 5 years after the day it commences.

Note An approval may be extended under s 25 (2) (a).

In this section:

relevant entities—see section 21 (6).

Division 3.4 General treatment plans—other matters